Delivery Order SPE2DB22D1202-SPE2DB25FVAZ4

Award Date 5/29/25
Potential Completion Date 6/20/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, with a ceiling value of $4,115.58 and a performance period through March 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,115.58 firm-fixed-price contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, with a performance period through May 28, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a ceiling value of $11,934.27. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of September 13, 2024. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a ceiling value of $12,346.74 and a performance period ending on February 11, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price of $11,934.27 and runs through September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical...
This is a $4,115.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a period of performance through July 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,346.74, is for the delivery of 4,568,125,149 units of the medication TESTOPEL 75 MG PELLETS 100S. The contract is a firm fixed-price delivery order with a performance period through May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
This federal contract award is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,956.18 and a completion date of September 24, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,978.09 fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a completion date of November 25, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVAZ4
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, with a ceiling value of $8,231.16. The contract is a firm fixed price delivery order, with a completion date of June 20, 2025. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/31/25, 1:42 AM